CX3CR1 and Alzheimer disease: As observed in AD, fractalkine receptor CX3CR1-knockout mouse models of PD also reveal the worsening of the phenotype [30], suggesting that the modulation of inflammation by fractalkine signaling can protect against microglial neurotoxicity.